Vaccines for Immune Mediated Diseases

Patients with immune-mediated inflammatory diseases (IMID) such as RA, IBD or psoriasis, are at increased risk of infection, partially because of the disease itself, but mostly because of treatment with immune-modulatory or immunosuppressive drugs. In spite of their elevated risk for vaccine-preventable disease, vaccination coverage in IMID patients is surprisingly low. Although the reduced quality of the immune response in patients under immunotherapy may have a negative impact on vaccination efficacy in this population, adequate humoral response to vaccination in IMID patients has been demonstrated for Hepatitis B, Influenza and Pneumococcal vaccination.

 

    Related Conference of Vaccines for Immune Mediated Diseases

    August 16-16, 2021

    3rd World Conference on Vaccine and Immunology

    Dubai, UAE
    August 27-28, 2021

    5th International Conference on Emerging Infectious Diseases

    Amsterdam, Netherlands
    September 20-21, 2021

    11th International Conference on Bacteriology and Infectious Diseases

    Cape Town, South Africa
    October 12-13, 2021

    International Conference on Vaccine and Vaccine research

    Manila, Philippines
    October 14-15, 2021

    13th Annual Conference on Clinical Immunology

    Cape Town, South Africa
    November 04-05, 2021

    9th World Summit on Immunology & Immunotherapy

    Prague, Czech Republic
    November 08-09, 2021

    International Conference on Immunology Research

    Las Vegas, USA
    February 07-08, 2022

    International Conference on Vaccine Research

    Paris, France
    March 21-22, 2022

    36th International Conference on Immunology

    Rome, Italy
    March 21-22, 2022

    15th Global Summit on Immunology and Cell Biology

    Tokyo, Japan

    Vaccines for Immune Mediated Diseases Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in